Annual Current Liabilities
$36.85 M
-$18.94 M-33.94%
December 31, 2023
Summary
- As of February 20, 2025, AVDL annual total current liabilities is $36.85 million, with the most recent change of -$18.94 million (-33.94%) on December 31, 2023.
- During the last 3 years, AVDL annual current liabilities has risen by +$21.75 million (+143.93%).
- AVDL annual current liabilities is now -57.41% below its all-time high of $86.54 million, reached on December 31, 2017.
Performance
AVDL Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$42.78 M
-$1.83 M-4.10%
September 30, 2024
Summary
- As of February 20, 2025, AVDL quarterly total current liabilities is $42.78 million, with the most recent change of -$1.83 million (-4.10%) on September 30, 2024.
- Over the past year, AVDL quarterly current liabilities has increased by +$5.93 million (+16.08%).
- AVDL quarterly current liabilities is now -56.03% below its all-time high of $97.31 million, reached on September 30, 2017.
Performance
AVDL Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
AVDL Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -33.9% | +16.1% |
| 3 y3 years | +143.9% | -16.9% |
| 5 y5 years | -4.0% | -16.9% |
AVDL Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -33.9% | +75.5% | -46.1% | +103.7% |
| 5 y | 5-year | -33.9% | +143.9% | -46.1% | +369.1% |
| alltime | all time | -57.4% | +954.5% | -56.0% | +1124.1% |
Avadel Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $42.78 M(-4.1%) |
| Jun 2024 | - | $44.61 M(-6.7%) |
| Mar 2024 | - | $47.81 M(+29.7%) |
| Dec 2023 | $36.85 M(-33.9%) | $36.85 M(-31.8%) |
| Sep 2023 | - | $54.05 M(+5.0%) |
| Jun 2023 | - | $51.50 M(-35.1%) |
| Mar 2023 | - | $79.36 M(+42.2%) |
| Dec 2022 | $55.79 M(+165.7%) | $55.79 M(+34.4%) |
| Sep 2022 | - | $41.51 M(-10.2%) |
| Jun 2022 | - | $46.22 M(+5.0%) |
| Mar 2022 | - | $44.02 M(+109.6%) |
| Dec 2021 | $21.00 M(+39.0%) | $21.00 M(+19.4%) |
| Sep 2021 | - | $17.59 M(+8.0%) |
| Jun 2021 | - | $16.28 M(+78.5%) |
| Mar 2021 | - | $9.12 M(-39.6%) |
| Dec 2020 | $15.11 M(-58.0%) | $15.11 M(-34.3%) |
| Sep 2020 | - | $23.01 M(-14.8%) |
| Jun 2020 | - | $27.02 M(-16.4%) |
| Mar 2020 | - | $32.34 M(-10.1%) |
| Dec 2019 | $35.98 M(-6.3%) | $35.98 M(+13.3%) |
| Sep 2019 | - | $31.76 M(-5.4%) |
| Jun 2019 | - | $33.58 M(+7.1%) |
| Mar 2019 | - | $31.36 M(-18.3%) |
| Dec 2018 | $38.38 M(-55.6%) | $38.38 M(-18.4%) |
| Sep 2018 | - | $47.02 M(-8.9%) |
| Jun 2018 | - | $51.61 M(-40.8%) |
| Mar 2018 | - | $87.19 M(+0.7%) |
| Dec 2017 | $86.54 M(+38.6%) | $86.54 M(-11.1%) |
| Sep 2017 | - | $97.31 M(+9.7%) |
| Jun 2017 | - | $88.71 M(+5.5%) |
| Mar 2017 | - | $84.05 M(+34.6%) |
| Dec 2016 | $62.42 M(+38.0%) | $62.42 M(+5.5%) |
| Sep 2016 | - | $59.19 M(+1.7%) |
| Jun 2016 | - | $58.19 M(-4.5%) |
| Mar 2016 | - | $60.94 M(+34.7%) |
| Dec 2015 | $45.25 M(-36.1%) | $45.25 M(-14.2%) |
| Jun 2015 | - | $52.75 M(-32.1%) |
| Mar 2015 | - | $77.65 M(+9.6%) |
| Dec 2014 | $70.84 M(+74.5%) | $70.84 M(+48.5%) |
| Sep 2014 | - | $47.72 M(+26.1%) |
| Jun 2014 | - | $37.84 M(+1.5%) |
| Mar 2014 | - | $37.30 M(-8.1%) |
| Dec 2013 | $40.59 M(+182.7%) | $40.59 M(+20.8%) |
| Sep 2013 | - | $33.61 M(+96.5%) |
| Jun 2013 | - | $17.10 M(+26.5%) |
| Mar 2013 | - | $13.52 M(-5.9%) |
| Dec 2012 | $14.36 M | $14.36 M(-11.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2012 | - | $16.24 M(-5.4%) |
| Mar 2012 | - | $17.18 M(-6.2%) |
| Dec 2011 | $18.31 M(-5.7%) | $18.31 M(+3.8%) |
| Sep 2011 | - | $17.64 M(-6.7%) |
| Jun 2011 | - | $18.91 M(+2.4%) |
| Mar 2011 | - | $18.46 M(-4.9%) |
| Dec 2010 | $19.42 M(-15.2%) | $19.42 M(-20.3%) |
| Sep 2010 | - | $24.36 M(+31.8%) |
| Jun 2010 | - | $18.48 M(-9.8%) |
| Mar 2010 | - | $20.50 M(-10.5%) |
| Dec 2009 | $22.90 M(+13.0%) | $22.90 M(+6.6%) |
| Sep 2009 | - | $21.48 M(+32.6%) |
| Jun 2009 | - | $16.20 M(-16.3%) |
| Mar 2009 | - | $19.36 M(-4.4%) |
| Dec 2008 | $20.25 M(-18.8%) | $20.25 M(+9.2%) |
| Sep 2008 | - | $18.55 M(-16.8%) |
| Jun 2008 | - | $22.30 M(-12.9%) |
| Mar 2008 | - | $25.61 M(+2.6%) |
| Dec 2007 | $24.95 M(+17.1%) | $24.95 M(-7.7%) |
| Sep 2007 | - | $27.02 M(+8.0%) |
| Jun 2007 | - | $25.02 M(+26.8%) |
| Mar 2007 | - | $19.74 M(-7.4%) |
| Dec 2006 | $21.31 M(-14.4%) | $21.31 M(+6.5%) |
| Sep 2006 | - | $20.02 M(+3.9%) |
| Jun 2006 | - | $19.27 M(-5.2%) |
| Mar 2006 | - | $20.33 M(-18.4%) |
| Dec 2005 | $24.90 M(+6.7%) | $24.90 M(+15.4%) |
| Sep 2005 | - | $21.58 M(-29.2%) |
| Jun 2005 | - | $30.49 M(+30.0%) |
| Mar 2005 | - | $23.45 M(+0.5%) |
| Dec 2004 | $23.33 M(+30.5%) | $23.33 M(+22.9%) |
| Sep 2004 | - | $18.98 M(0.0%) |
| Jun 2004 | - | $18.98 M(-2.0%) |
| Mar 2004 | - | $19.38 M(+8.4%) |
| Dec 2003 | $17.87 M(+174.5%) | $17.87 M(+127.1%) |
| Sep 2003 | - | $7.87 M(+0.9%) |
| Jun 2003 | - | $7.80 M(+8.9%) |
| Mar 2003 | - | $7.16 M(+10.0%) |
| Dec 2002 | $6.51 M(+0.7%) | $6.51 M(+18.2%) |
| Sep 2002 | - | $5.51 M(-14.7%) |
| Dec 2001 | $6.46 M(+5.7%) | $6.46 M(+5.7%) |
| Dec 2000 | $6.11 M(+74.9%) | $6.11 M(+74.9%) |
| Dec 1999 | $3.50 M(-19.7%) | $3.50 M(-19.7%) |
| Dec 1998 | $4.35 M(+6.2%) | $4.35 M(-3.3%) |
| Mar 1998 | - | $4.50 M(+9.8%) |
| Dec 1997 | $4.10 M(-14.6%) | $4.10 M(-14.6%) |
| Dec 1996 | $4.80 M | $4.80 M(+9.1%) |
| Mar 1996 | - | $4.40 M |
FAQ
- What is Avadel Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals annual current liabilities year-on-year change?
- What is Avadel Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals quarterly current liabilities year-on-year change?
What is Avadel Pharmaceuticals annual total current liabilities?
The current annual current liabilities of AVDL is $36.85 M
What is the all time high annual current liabilities for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high annual total current liabilities is $86.54 M
What is Avadel Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, AVDL annual total current liabilities has changed by -$18.94 M (-33.94%)
What is Avadel Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of AVDL is $42.78 M
What is the all time high quarterly current liabilities for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high quarterly total current liabilities is $97.31 M
What is Avadel Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, AVDL quarterly total current liabilities has changed by +$5.93 M (+16.08%)